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Abstract
Neuropeptides constitute an important part of the nervous system, since the simple nerve
nets (i.e. of Hydra). The assigned functions of these peptides vary enormously. For
instance, besides inhibiting or stimulating the release of some hormones, they can be
responsible for tentacle contraction of the Hydra, dropping the tail of the lizard, postnatal
care of the beetles and also aggressiveness of humans. They perform these tasks via
activating their cognate GPCRs, which are hypothesized to be coevolved with their ligand
neuropeptides. In this chapter, we will introduce the concept of neuropeptide, its intracel-
lular maturation process, characteristics of some typical neuropeptide families and the
common properties of their cognate GPCRs. At last, we will try to give information about
the widely used methods for studying GPCR-neuropeptide interactions.
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1. Introduction
Neuropeptides are polypeptides expressed in and secreted from neurons. They are produced
as propeptides, cleaved into smaller fragments and matured via posttranslational modifica-
tions, differing from classical neurotransmitters in size, concentration and secretion mecha-
nisms. They are expressed everywhere in the nervous system, take role in synapsis and can
have distal target organs, as do the hormones.
Neuropeptides constitute the most diverse class of molecules in the body. They have various
roles in development, reproduction, physiology and behavior of the animals. There are at least
70 known genes coding for neuropeptide precursor proteins, called prepropeptides, in
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mammals and 42 genes in Drosophila. Secreted forms are processed from these prepropeptides
and can vary from 5 to 80 amino acids in length. They coexist with classical neurotransmitters;
for instance, neurotensin is released with dopamine [1] or vasoactive intestinal peptide with
acetylcholine [2]. They mostly act on G-protein coupled receptors (GPCRs) and transduce their
signals via intracellular secondary messenger systems.
2. Evolution of neuropeptide signaling
Simple nerve nets have evolved since the earliest animals like cnidarians (such as Hydra, sea
anemones and jellyfish). Even they have no real brain, their nervous system includes secretory
vesicles and produces different types of neuropeptides [3]. Neuropeptides constitute an impor-
tant part of their nervous system. Therefore, neuropeptide signaling should have been evolved
before the divergence of cnidarians and bilaterians, which means more than 550 million years
of evolution.
Secretory vesicles of cnidarian nervous system are accumulated at the synapses [4, 5]. This
may help for directed-signal transmission such as tentacle contraction of Hydra [6]. However,
in vertebrates, the peptide secretory vesicles are not localized only to the synapse but distrib-
uted also along the nerve body and soma. Because neuropeptides interact mostly with GPCRs,
their action mechanism is slower than classical neurotransmitters. This fact should be disad-
vantageous for the peptidergic nervous system of the Hydra. However, it was found that they
have evolved different receptor-binding mechanisms to overcome this problem. For instance,
mammalian RFamide neuropeptides activate different GPCRs and this activation leads to a
slow response. On the other hand, Hydra-RFamide I and II act through a so-called peptide-
gated ionotropic receptor, which is a trimeric complex of ion channels [7]. This system results
in an advantage like faster transmission than that of classical neuropeptide-GPCR system, in
absence of classical neurotransmitters.
In evolution of neuropeptide signaling, echinoderms are the second most important because
they constitute an intermediate step between Protostomia (which include fruit fly) and
Deuterostomia (which include both the vertebrates and echinoderms). Echinoderm neuropep-
tides are suggested to be involved in unusual mechanisms such as autotomy (dropping the tail
of the lizard) and regeneration, or control of stiffness of connective tissue [8].
The major assumptions behind the diversity of neuropeptide genes are tandem duplications
and following substitutions. Neuropeptide sequences are conserved in most cases (such as
oxytocin family). However, some neuropeptide sequences show variations, and these varia-
tions can lead to differences in half-life, receptor affinity or expression profiles. Finally, these
changes can generate a pressure in the direction of neuropeptide-receptor coevolution. Addi-
tionally, the mature peptides that are processed from the same gene can have sequence
variations. These variations cannot be explained by gene duplication. An example for this is
37 peptide products of metamorphosin A prepropeptide of sea anemone [9]. All of these
peptides can show functional redundancy, which means that they can be coexpressed,
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cosecreted and activating the same receptor. In a study on Drosophila genus, multiple copies of
peptides from the same prepropeptide were analyzed [10], and it was found that they were
highly conserved and under stabilizing selection. The numbers of peptide copies were the
same within the genus (except FMRFamides). This conservation is important for receptor
selectivity, affinity or the final response. Additionally, the researchers showed that the most
conserved peptides were the most potent ligands for their receptors. Finally, these results on
Drosophila neuropeptides supported the idea of evolutionary pressure of peptide-receptor
coevolution on neuropeptide selection. This idea was proposed also for the vertebrate neuro-
peptides. Some regions of the vertebrate peptides are conserved, and these regions are thought
to be the most important parts for functioning. For instance, the C-terminal residues of
tachykinins are strictly conserved within vertebrates, and this region has roles in binding with
tachykinin receptors. However, these similarities between neuropeptides of different species
do not have to mean cross-reactivity with the receptors of different species [11, 12]. And this
fact would be a support for the discussion of peptide-receptor coevolution.
3. Processing and trafficking of neuropeptides
Neuropeptides are the gene products that range from 5 to 80 amino acids in length. They born
like prepropeptides, which contain an N-terminal signal sequence (between 15 and 40 residues
in length). A typical signal sequence contains a positively charged region, a hydrophobic
region and some polar but uncharged amino acids until the cleavage site, in the order [13].
This signal sequence is responsible for the anchorage of prepropeptide to the endoplasmic
reticulum (ER) membrane via a complex called translocon, where folding and signal peptide
cleavage occur. In some prepropeptides, the N-terminal region includes a signal anchor instead
of a signal sequence. This signal anchor is responsible for the anchorage of precursor protein to
the ER membrane but not cleaved. An example for this signal anchor can be given for the
precursor of Allatostatin CC peptides of insects [14]. These signal anchors produce single-pass
membrane proteins, which can act as juxtacrines in nervous system.
Cleaved propeptides are exported to the Golgi for further processing. Mainly, two types of
“trypsin-like” endopeptidases are responsible for the cleavage of propeptides. These enzymes
are called proprotein convertase 1 (PC1/3) and 2 (PC2). Seven PC types are expressed in
mammals, but only three PCs in fruit fly (Amontillado, Dfurin1 and Dfurin2). PCs recognize
and cleave the C-terminal site of dibasic residues such as KR or RR, especially of R-X-(R/K/X)-
R motif on propeptides [15]. However, cleavage preferences differ within organisms. For
instance, if valine or leucine is placed in place of X, the site will become resistant to cleavage
by vertebrate PC (furin) but will be efficiently cleaved by insect PCs (Dfurin) [16]. In processing
of neuropeptides, mammalian PC1 and PC2 and fly Amontillado are widely expressed in
neurons, whereas furins have ubiquitous expression [17, 18].
Cleaved propeptide contains a basic C-terminus, which is further cleaved by carboxypeptidase
E. In order to stabilize peptide structure against degradation, C-terminal glycine of most of
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intermediate propeptides is amidated. This amidation is a multistep process of two enzymes in
invertebrates, while vertebrates have a multifunctional enzyme to perform this task, called as
peptidylglycine alpha-amidating monooxygenase (PAM).
Mature peptides are transported in large dense core vesicles (DCV), which are different from
small vesicles delivering classical neurotransmitters. Furthermore, posttranslational modifica-
tions occur in DCVs. These modifications may include acetylation, sulfation, glycosylation,
phosphorylation and cyclization. Some peptides can be processed even after secretion to the
extracellular space. For instance, it was found that CPA6 of A/B family of carboxypeptidases is
secreted to the extracellular matrix, cleaves hydrophobic C-terminal residues of neuropeptides
and can lead to activation of Angiotensin I while degradation of some other peptides [19].
The engagement of DCVs to the nerve terminals is a very rare event. This is because DCVs
respond to the changes in Ca+2 content and hundreds of spikes are needed to stimulate a DCV
to release its content [20]. Even in these rare events, very large amounts of neuropeptides are
released to the synaptic cleft where they are enzymatically cleaved and degraded. On the other
hand, unlike neuropeptides, classical neurotransmitters are very rapidly transported to the
membrane, easily released and recycled from the synaptic cleft.
Finally, one precursor protein can generate more than one neuropeptide and these peptides
can be distinct or the same. Additionally, a precursor molecule can be alternatively spliced to
yield different mature neuropeptides in different cells [21].
4. Types, cognate GPCRs and functions
As the simplest nervous system, cnidarians express at least 17 different neuropeptides,
which can be grouped in three: FMRFamide-like peptides (FLPs), GLWamides and Hym-
355 [3]. The neuropeptides expressed in worm C. elegans are also classified in three major
groups, depending on their structural and functional similarities [21]. These groups are
called as insulin-like peptides (ILPs), FLPs and neuropeptide-like peptides (NLPs). Verte-
brate neuropeptides can be clustered in a wide range of families according to sequence
similarities [22]. However, in human, neuropeptides expressed from 96 different genes were
clustered in 22 distinct families together with the no-family peptides and deposited in
neuropeptide databases [23].
In a study of metazoan (all animals) propeptides, neuropeptides of 10 phyla were taken and
clustered in about 80 families according to their similarities within propeptide sequences [22].
Twenty-two of these families showed high similarity with each other. These included
FMRFamides, LWamides, myoinhibitory peptide (MIP), neuropeptide FF and gonadotropin
inhibitory hormone (GnIH).
In this chapter, we will introduce some of the neuropeptides that show conservation within
species (as reviewed from the study of Jékely [22]) or that are specific examples for vertebrates
and exclude the ligands interacting with non-GPCR targets. Summary of all mentioned neuro-
peptide families is given in Table 1.
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Peptide family Examples for active
peptides
Expressed in Structural similarity Function(s) Cognate GPCR
FMRFamide-
like peptides
FMRFamide Mollusks Tetrapeptide FMRFamide Cardioacceleration nd
FLP peptides Nematodes C-terminal FMRFamide Control of feeding, reproduction, sensation Various NPRs
CCK/gastrin-type peptides C-terminal QFamide Control of feeding behavior, energy
homeostasis
FMRFamide-like peptides Arthropods and
Cnidaria
C-terminal RFamide Cardioacceleration FMRFamide and
sulfakinin receptors
Gonadotropin-inhibitory
hormone
Vertebrates Inhibition of gonadotropin release GPR147
Neuropeptide FF Nociception NPFFR1, NPFFR2
Pyroglutamylated
RFamide peptide
Control of feeding GPR103
Prolactin-releasing peptide Stimulation of prolactin release PrRP receptors
Kisspeptin Reproductive development Kisspeptin receptor
Tachykinins Substance P-like
tachykinins
Cnidaria, nematodes,
arthropods
C-terminal FXGXRamide Promotion of aggression, sexual activity and
fecundity
NK-1
Locustatachykinins Invertebrates Stimulation of muscle contractions NKRs
Eledoisin Eledone C-terminal F(Y/I)GLMamide Vasodilation, hypotension NK-1
Sialokinin I and II Arthropods Vasodilation NKRs
Skin tachykinins Amphibians C-terminal FXGLMamide Ion transport
Brain/gut tachykinins Submammalian
vertebrates
Vasodilation, smooth muscle contraction
Neurokinin A Mammals Regulation of inflammation and pain
responses
NK-2
Neurokinin B Regulation of reproduction, secretion of
gonadotropin-releasing hormone
NK-3
Neuropeptide K Regulation of sensation NK-2
Neuropeptide γ Regulation of reproduction NK-2
Substance P NK-1
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Peptide family Examples for active
peptides
Expressed in Structural similarity Function(s) Cognate GPCR
Regulation of inflammation and pain
responses, promotion of aggression
Vasopressin/
oxytocin
Conopressins Invertebrates Sequence similarity and disulfide
bridge between the 1st and 6th
residues
Regulation of reproduction Conopressin receptor
Diuretic hormones Regulation of water balance Diuretic hormone
receptor
Mesotocin Submammalian
vertebrates
Mesotocin receptor
Vasopressin Vertebrates Antidiuretic activity V1A, V1B and V2
Oxytocin Contraction of the uterus, lactation OXTR
Myoinhibitory
peptide/
GWamides
Sex peptide From cnidarians
through annelids
C-terminal W(X)8 W–amide Increasing egg laying, reduction in the
female’s receptivity, stimulation of juvenile
hormone synthesis
SPR
Myoinhibitory/allatostatin-
B peptide
C-terminal W(X)6 W–amide and
disulfide bridge
Inhibition of contractions of hindgut and
oviduct, ecdysteroid synthesis and juvenile
hormone synthesis
MIPR
Prothoracicostatic
hormone
Regulation of reproduction, release of
ecdysone hormone
Torso (not GPCR),
also activates SPR
APGWamides Mollusks Tetrapeptide Sex organ growth, regulation of reproduction nd
Orexin/
allatotropin
Allatotropin Arthropods (except
Drosophila), mollusks,
annelids
N-terminal GFK
residues
No
structural
similarity
Stimulation of juvenile hormone synthesis,
cardioacceleration, myostimulation
AT receptor
Orexin A Mammals Sequence similarity Sleep and wakefulness OX1 and OX2
Orexin B
GnRH/
corazonin/
AKH
Corazonin Arthropods N-terminal pyro-
glutamate
cardioacceleration, melanization and
developmental processes
Corazonin receptor
Adipokinetic hormone Arthropods Phe in 8th
position
Mobilization of carbohydrates, lipids and
proteins from the fat body
AKH receptor
GnRH-like peptides Annelids and
mollusks
Following
HWS
residues
Stimulation of testosterone and progesterone
synthesis
GnRHR
GnRH Vertebrates Stimulation of gonadotropin release
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Peptide family Examples for active
peptides
Expressed in Structural similarity Function(s) Cognate GPCR
GnRH1 and GnRH2
receptors
Neuropeptide
Y
Neuropeptide Y Vertebrates and
invertebrates
C-terminal amidation and a
pancreatic polypeptide fold
structure
Regulation of blood pressure and feeding
behavior
Y1,2,4,5 and y6
Peptide tyrosine tyrosine Vertebrates Inhibition of gastric motility and electrolyte
secretion
Pancreatic polypeptide Vertebrates Inhibition of pancreatic exocrine secretion
Somatostatin/
allatostatin C
Allatostatin C Arthropods C-terminal PISCF
and a disulfide
bridge
No
structural
similarity
Inhibition of juvenile hormone synthesis AlstR-C
SST14 Vertebrates Sequence similarity Inhibition of growth hormone release SSTR1, SSTR2A,
SSTR2B, SSTR3,
SSTR4 and SSTR5
SST28
Galanin/
allatostatin A
Allatostatin A Arthropods C-terminal
FGLamide
No
structural
similarity
Inhibition of juvenile hormone synthesis,
regulation of food intake
AST-A receptors
Galanin Vertebrates N-terminal similarity
and C-terminal
amidation
Nociception, feeding and osmotic regulation GalR1, GalR2 and
GalR3
VIP/PACAP α-Pigment dispersing
factor
Invertebrates C-terminal
amidation
No
structural
similarity
Regulation of circadian clock PDF receptor
β-Pigment dispersing
factor
VIP Vertebrates β-turns and α-helical
structures
VPAC1 and VPAC2
PHI
PHM
PHV
PACAP27 PAC1, VPAC1 and
VPAC2
PACAP38
Table 1. Summary of the neuropeptide families and the similarities within these families.
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4.1. FMRFamide-like peptides
Genome searches and mass spectrometry-based methods on nematode C. elegans yielded
around 30 genes encoding for FLPs. These peptides share a common C-terminal motif like
FMRF residues. RNAi studies on these genes showed that FLPs can have roles on different
processes such as hyperactivity, timing of egg laying, number of laid eggs, fat metabolism and
acetylcholine signaling [24–26]. In mollusk Macrocallista nimbosa, this neuropeptide takes role
in cardioexcitatory activity [27]. FLPs are expressed in all of the animal species. However, the
conserved C-terminal residues may become FMRFamide, QFamide or RFamide. In arthro-
pods, sulfakinins, myosuppressins, RFamides and other extended FMRFamides have the
common C-terminal amidated RF residues. Myosuppressins seem to be restricted to crusta-
ceans and insects and have a role in inhibiting contractions of the hindgut, cardiac muscle and
release of adipokinetic hormone [28, 29]. Extended FMRFamides of arthropods affect respira-
tion, heart rate, gut motility and muscle contractions. Drosophila sulfakinin (drosulfakinin) was
shown to regulate locomotor behavior [30], feeding behavior [31] and smooth muscle contrac-
tion [32]. FMRFamides act through two types of receptors. Most of them activate GPCRs.
However, FMRFamides of snail Helix aspersa lead to an excitatory response in amiloride-
sensitive Na+ channels [33].
4.2. Tachykinins
Vertebrate tachykinins are one of the largest groups of neuropeptides expressed in both
invertebrates and vertebrates. They contain conserved C-terminally amidated motifs such as
FXGLM residues, while some of arthropod tachykinins show FXGXRamide conservation.
These five residues are very conserved but not vital for receptor activation, instead phenylala-
nine at the fifth position and the C-terminal amidation are essential for their activity. They can
be localized both to the brain and the gut of various organisms, as well as the skin of amphib-
ians. They can be secreted from the enteroendocrine cells of mammals as paracrines or as true
hormones.
Human tachykinin family includes neurokinin A (NKA), neurokinin B (NKB), neuropeptide K
(NPK), neuropeptide γ (NPγ) and substance P (SP), which are expressed from two genes.
These peptides activate three types of GPCRs: NK-1, NK-2 and NK-3. SP interacts with NK-1,
while NKA with NK-2 and NKB with NK-3. Higher concentrations of SP in patients with
personality disorders were correlated with aggressive behavior [34]. It was also shown that
Drosophila tachykinins have aggression-promoting functions [35] and control systemic lipid
homeostasis [36]. Tachykinin-like natalisin peptide regulates sexual activity and fecundity of
arthropods [37]. Another tachykinin family peptide, eledoisin, was identified from the salivary
glands of mollusk Eledone in 1962 [38]. And, eledoisin and kassinin were shown to be
expressed and stimulated ion transport in the frog skin [39].
4.3. Vasopressin/oxytocin
Vasopressin (VP) and oxytocin (OXT) are members of the same family due to their sequence
similarity. They are conserved from arthropods to mammals. Vertebrate VP/OXT peptides are
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expressed from different genes. Processing of propeptides of vasopressin gene produces three
peptides called VP, neurophysin II and copeptin, while processing of oxytocin gene produces
only OXT and neurophysin I peptides. OXT and VP bind with their corresponding
neurophysins, OXT with neurophysin I and VP with neurophysin II. These neurophysins are
responsible for the storage of VP and OXT inside DCVs. In physiological pH, VP and OXT do
not bind with neurophysins and circulate freely in the plasma. Both mature VP and OXT are
nine amino acids in length, eight of which are identical and contain a disulfide bridge between
the first and sixth residues [40], while neurophysins have seven bridges. The first cysteine and
the following tyrosine residues play the major role in neurophysin binding [41]. Although VP
and OXT show sequence similarity, their functions differ from each other. VP has antidiuretic
activity and released as a response to increased blood plasma osmolarity, while OXT has roles
in contraction of the uterus and in lactation and is stimulated with suckling movement of the
newborn. VP and OXT receptors constitute a big family of GPCRs. There are three types of
vasopressin receptors: V1A, V1B and V2. However, only one type of oxytocin receptor was
identified: OXTR [42].
Invertebrate homologous peptides also contain the disulfide bridge at the same position and
five or six amino acids of the peptides are well conserved. The invertebrate homologs of
vertebrate VP/OXT peptides are conopressins and diuretic hormones (DH) [43].
4.4. Myoinhibitory peptide/GWamides
These peptides are expressed from Cnidaria to Annelids but not present in vertebrates. This
family of peptides shares a common motif like W(X)6Wand includes various similar peptides
such as myoinhibitory/allatostatin-B peptide (MIP/AST-B), sex peptide (SP), prothoracicostatic
hormone (PTTH) and GWamides (of mollusks).
The first AST-B peptide is identified in Locusta migratoria as an MIP. It inhibits contractions of
hindgut and oviduct, as well as ecdysteroid synthesis. It has a W(X)6Wamide motif on its C-
terminus and is widely expressed in the central nervous system. Similar peptides are identified
in Gryllus bimaculatus and found that they inhibited juvenile hormone synthesis in corpora
allata. Therefore, they are called as allatostatins.
SP is found in Drosophila male accessory glands and regulates mating behaviors of the females.
During mating, SP is released from male’s ejaculatory duct and acts on the corresponding
receptor on the female reproductive duct, increases egg laying and reduces the female’s recep-
tivity. This peptide is 36 amino acids in length. N-terminal eight residues are responsible for
sperm binding and stimulation of juvenile hormone synthesis. Following 12 amino acids have
roles in innate immune responses against bacteria. And the C-terminal 16 amino acids have role
in postmating responses. A disulfide bridge is localized to the C-terminal part of the peptide. In
addition, there is an internal W(X)8Wmotif instead of W(X)6Wamide of the others. Therefore, the
tryptophan residues on both peptides seem to be important for receptor binding [44]. Sex
peptide receptor (SPR) of Drosophila is CG16752, and this receptor is expressed in female repro-
ductive organs and in the central nervous system of both genders. It is proposed to be Gαi-
coupled. MIP and SP both activate SPR, but MIP has lower affinity for this receptor [45].
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APGWamide is a mollusk tetrapeptide. It is mostly correlated with sex organ growth and
reproduction of the animal.
PTTH is a homodimer of two identical peptide chains that are hold together by disulfide
bridges [46]. It regulates the reproduction and release of ecdysone hormone. The target recep-
tor of PTTH is Torso, which is a kind of receptor tyrosine kinase [47]. However, it can also
activate SPR [48].
4.5. Orexin/allatotropin
Allatotropin (AT) was first identified in Manduca sexta, stimulating juvenile hormone synthesis
[49]. These peptides show conservation on their N- and C-termini. They include glycine, phenyl-
alanine and a following basic residue in the order in their N-termini (for instance, GFK residues).
This N-terminus is important for biological activity of the peptide. On their C-termini, aromatic
amino acids are conserved, followed by an amide group (such as R-amide or Y-amide). These
peptides are not identified in Drosophila, Apis mellifera andNasonia vitripennis. However,Drosoph-
ila expresses sex peptide for the same function. Therefore, it seems that different peptides may
work for the same function in different species. Additionally, AT has other roles such as
cardioacceleration, stimulation of muscle contractions and myostimulation in the gut [50–52].
Orexin receptors (or hypocretin receptors) are found to be orthologs of AT receptors, via
similarity on their C-terminus [22]. However, their peptide ligands are not structurally or
functionally related. Orexin peptides are about 28–33 amino acids in length. They are hypo-
thalamic neuropeptides and have roles mainly in sleep and wakefulness [53].
4.6. GnRH/corazonin/AKH
Gonadotropin releasing hormone (GnRH) is the peptide-stimulating gonadotropin release in
vertebrates. However, invertebrates, such as annelids and mollusks, also express GnRH-like
peptides. Octopus GnRH induces synthesis of testosterone and progesterone in the ovary and
testis, respectively. From tunicates to mammals, GnRH sequence shows a high conservation. It
is a decapeptide that has an N-terminal pyroglutamine and following HWS residues and C-
terminal PGamide residues [54].
Insects express corazonin and adipokinetic hormone (AKH), instead. Corazonin is 11 amino
acids in length and has a cardioacceleratory effect in cockroaches. However, other actions are
defined in other insects, such as melanization in locusts and developmental pathways in other
insects such asM. sexta and Bombyx mori. AKH is generally 8–10 amino acids in length. It has an
N-terminal pyroglutamate, C-terminal amidation and at least two aromatic residues in between.
These aromatic residues (at positions 4 and 8) are important for receptor binding. Its structure
exhibits a β-turn between these positions. It regulates mobilization of carbohydrates, lipids and
proteins from the fat body. Additionally, it has roles in cardioacceleration as corazonin.
Vertebrate GnRH receptors and insect AKH receptors are closely related. Drosophila corazonin
receptor is clustered in the same family of AKH and VP receptors. However, corazonin
receptor is highly selective for corazonin peptide [55].
Ligand86
4.7. Neuropeptide Y
Neuropeptide Y (NPY) family of vertebrate neuropeptides includes NPY, peptide tyrosine tyro-
sine (PYY) and pancreatic polypeptide (PP). These peptides are C-terminally amidated and show a
hairpin-like structure called pancreatic polypeptide fold (PP-fold). This fold was composed of one
polyproline helix and one α-helix running antiparallel to each other [56]. Five types of Y receptors
(for NPY family) are expressed in mammals (Y1,2,4,5 and y6). It is proposed that hydrophobic
surface of the PP-fold is responsible for receptor binding. NPY is localized to the brain, while PP
and PYY are localized to the gastrointestinal tract. NPY is a highly conserved peptide from frog to
human. Circulating NPY acts on regulation of blood pressure and eating behavior [57].
A mollusk NPY was identified in Lymnaea stagnalis via activation assays on its corresponding
NPY receptor homolog [58]. This peptide was 39 amino acids in length and very similar to the
vertebrate NPYs. Invertebrate NPY prepropeptides lead to two peptides, one is NPY and the
other one is C-terminal peptide of NPY (CPON). The important residues that are responsible
for the PP-fold of vertebrate NPYs are conserved in mollusk NPYs, but only some of them are
conserved in Drosophila NPYs. Additionally, C-terminal four residues and amidation, which
are essential for the activity of the peptide [59], are conserved between vertebrate and inverte-
brate NPYs. Lymnaea NPY has role in regulation of energy consumption processes, while the
other invertebrate NPYs mostly affect food intake of the animal [60].
4.8. Somatostatin/allatostatin C
Allatostatin C (AST-C) is the arthropod homolog of vertebrate somatostatin (SST). SST is found
as the inhibitor of growth hormone release from the pituitary gland. And AST-C is the
inhibitor of juvenile hormone synthesis in corpora allata. From the same SST propeptide, one
peptide with 14 amino acids and another with 28 amino acids are released, which are secreted
from and acting on different tissues such as central and peripheral nervous system, as well as
gastrointestinal tract. Both SST and AST-C peptides exhibit a disulfide bridge, which is impor-
tant for receptor affinity [11]. The pharmacophore of SST is defined with FWKT residues. And
it functions for the inhibition of pituitary hormones such as growth hormone, thyroid stimu-
lating hormone and adrenocorticotropic hormone. SST acts on six different subtypes of SST
receptors (SSTRs), SSTR1, SSTR2A, SSTR2B, SSTR3, SSTR4 and SSTR5.
On the other hand, AST-C has highly conserved C-terminal PISCF amino acids. In addition to
juvenile hormone inhibition, it inhibits heart muscle contraction in Drosophila.
4.9. Galanin/allatostatin A
Galanin peptide is first identified in porcine intestine. Human galanin propeptide produces two
peptides, galanin (30 amino acids) and galanin-message associated peptide (GMAP), after cleav-
age. N-terminal residues and a C-terminal amidation (except in human) of galanin are highly
conserved. These peptides are expressed in both central and peripheral nervous systems and
have roles in nociception, feeding and osmotic regulation, via acting on three GPCRs; GalR1,
GalR2 and GalR3.
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Allatostatin A (AST-A) exhibits a conserved C-terminal FGLamide group, which is not
similar to galanin peptide. However, these two peptides activate ortholog receptors of verte-
brates and arthropods. AST-A peptides are mainly expressed in brain and gut and serve for
the inhibition of juvenile hormone synthesis and regulation of food intake, as similar to other
AST types.
4.10. Vasoactive intestinal peptide/pituitary adenylate cyclase activating peptide
Expression of vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating
peptide (PACAP) is restricted to vertebrates. They belong to the glucagon/secretin super-
family that also includes glucagon, secretin, growth hormone releasing hormone (GHRH)
and gastric inhibitory peptide (GIH). VIP and PACAP show structural similarity on their N-
terminal 27 amino acids. VIP is expressed in both central and peripheral nervous system,
while PACAP in hypothalamus, central nervous system, respiratory and gastrointestinal
tract. Mature VIP peptide is very well conserved in both mammals and nonmammalian
vertebrates. Short PACAP (27 amino acids in length) is restricted to mammals, but the longer
form (38 amino acids in length) can be found also in nonmammalian vertebrates [61]. It
exhibits an α-helical structure on binding to the receptor but can fold into different second-
ary structures in different solutions. PACAP is responsible for the release of growth hor-
mone, luteinizing hormone, adrenocorticotropic hormone, follicle-stimulating hormone and
prolactin from the pituitary gland, acts on testis and ovary and stimulates insulin and
glucagon release [62]. VIP was discovered due to its vasodilatory effects [63]. It can act as
both a paracrine or a hormone. However, its half-life is very short when compared to
classical hormones [64]. VIP gene produces other forms of peptides such as peptide histidine
isoleucine (PHI), peptide histidine methionine (PHM) and peptide histidine valine (PHV), in
different organisms. However, the information about the functions of these peptides is
limited.
High similarity between PACAP and VIP peptides make them to activate the same receptors,
but with different affinities. Three different PACAP receptors are identified (PAC1, VPAC1
and VPAC2). And two types of PACAP selectivity were detected in tissues. In one type, PAC1
receptor has high affinity for PACAP peptides (PACAP27 and PACAP38) and expressed in
anterior pituitary and hypothalamus. For the second selectivity, VPAC1 and VPAC2 receptors
showed affinity for both PACAP and VIP peptides, and this was detected in peripheral organs.
All of these receptors are known to activate adenylate cyclase, leading to cAMP stimulation. In
other circumstances, they can stimulate Ca+2 levels and phospholipase D.
Pigment dispersing factor (PDF) receptors are homologs of VPAC2 in invertebrates. They regu-
late circadian clock. In nematodes, they regulate locomotion, but in crustaceans, they regulate
pigment movements in the retina.
There are other additional neuropeptide families that interact with GPCRs, such as proopiome-
lanocortin (POMC) family, which is typical for its precursor complexity and others. However, we
will not go into details of other families in this chapter.
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5. Common features of neuropeptide GPCRs
Neuropeptides activate various receptors most of which are GPCRs. Some neuropeptides as
given in Section 4.4 can bind to membrane receptors that couple with receptor tyrosine kinases
(i.e. insulin receptors and Torso for PTTH). Some small neuropeptides do not have defined
receptors but are ligands for other peptides or enzymes (i.e. 7B2 binding to PC enzymes and
neurophysins binding to VP or OXT). Most of the others interact with their cognate GPCRs
from the extracellular region and activate a downstream signal transduction pathway. Peptide
GPCRs belong to either Class A (rhodopsin-like) or Class B1 (secretin-like) receptor.
Class A GPCRs exhibit two types of ligand-binding pockets. In one type, the hydrophobic
ligand interacts with the transmembrane (TM) region, and the N-terminal region together with
the second extracellular loop (ECL2) forms a closed lid-like structure (i.e. rhodopsin and S1P
receptors that have highly hydrophobic ligands). However, in the second type, ECL2 folds
over the extracellular region of the receptor and forms a pocket-like vacancy, which is exposed
to the soluble environment. Peptide GPCRs show the characteristics of this latter binding
pocket. Here, ECL2 comprises sheets, instead of β-hairpin loops of rhodopsin or helices of
adrenergic receptors. Another feature of Class A GPCRs is the presence of a disulfide bridge
between transmembrane domain 3 (TM3) and ECL2. This bridge is important for the stability
of the receptor and serves as a barrier against conformational changes in this region, which is
important for the ligand affinity. In a review on the defined 3D structures of Class A GPCRs,
the depths of bound ligands were compared with regard to positioning of TM4 [65]. Within the
Class A GPCRs that exhibit open binding pockets, amines (i.e. doxepine) were interacting
deeply, while peptides and nucleoside ligands were closer to the extracellular environment.
Three TM regions (TM3, TM6 and TM7) of Class A GPCRs were proposed to have consensus
binding residues. These consensus amino acid positions are 3.32, 3.33, 3.36, 6.48, 6.51 and 7.39
(Ballesteros-Weinstein numbering). However, peptide receptors such as neurotensin receptor
(NTSR) and allatostatin C receptor (AlstR-C) were shown to have different interactions within
the TM regions. For instance, neurotensin forms salt bridges and hydrogen bonds with the
Y3.29, R6.54, R6.55, F6.58 and Y7.35 residues of NTSR1 [66]. Additionally, AST-C was binding
with proposed AlstR-C model from the extracellular site, except for the two amino acids of
TM6 (I6.59 and F6.60 residues) [67]. In addition to these consensus residues, Venkatakrishnan
et al. proposed that the positions 6.48 and 6.51, which were conserved within Class A GPCRs,
might be responsible for the structural folding of the binding pocket, forming a scaffold
consensus [65]. However, the evidences for these consensus residues of binding pockets and
scaffold interfaces of peptide GPCRs are limited.
Secretin-like neuropeptide GPCRs include the receptors for VIP/PACAP, PDF (in inverte-
brates), calcitonin, insect DHs, corticotropin releasing factor (CRF), GHRH and parathyroid
hormone (PTH) peptides. There is less information about the structures of secretin-like neuro-
peptide receptors than that of rhodopsin-like receptors. Within the receptors mentioned above,
the only solved full-length structures come from CRF1 receptor (PDB entry: 4Z9G) and calci-
tonin receptor (PDB entry: 5UZ7). Additionally, there are ligand-bound structures of glucagon
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receptors of which the ligand is not a neuropeptide. Because glucagon receptor has the most
well-known structure and secretin receptor is the most studied in this class, we will use them
as examples to understand ligand binding of secretin-like neuropeptide GPCRs, even though
they are not neuropeptides. Additional information comes from the N-terminal region of
ligand-bound structures of PAC1 (PDB ID: 2JOD) and PTH receptor (PDB ID: 3C4M), together
with the free forms of V2 receptor (PDB ID: 2X57) and GHRH receptor (PDB ID: 2XDG).
In order to understand ligand-binding features of this class, we need to look at their ligands.
Neuropeptide ligands that couple with secretin-like GPCRs have a common secondary struc-
ture of at least one α-helix. As that of glucagon peptide, PACAP and CRF exhibit two α-
helices. VIP, PTH and calcitonin peptides have only one helical structure. On the other hand,
the common feature of these family receptors is that they have a long and complex N-terminus
that may include three disulfide bridges forming an α-β-β-α fold [68]. This N-terminal region
of the receptors is shown to be important in ligand binding. Provided by the experimental
structure of human glucagon receptor, another region on the N-terminus was identified as
“stalk” at the top of TM1. And mutagenesis studies on this stalk region proved that it was
important for ligand binding, by providing a defined conformation of N-terminal loop with
regard to TM1 [69, 70]. As another hypothesis, Dong et al. proposed an endogenous agonism
for the N-terminal region of secretin receptor [71]. Here, binding of C-terminus of the ligand to
the N-terminus of the receptor results in a conformational change that results in movement of a
hidden tripeptide region and becomes an endogenous agonist for the receptor itself. This
tripeptide region consists of WDN residues (inside one of the N-terminal helices) on secretin
receptor, which are also conserved for calcitonin and VPAC1 neuropeptide receptors.
According to FRET study by Harikumar et al., C-terminal part of secretin peptide was in
proximity to the groove above the β-hairpin of receptor N-terminus, while N-terminal part of
it was in proximity to ECL3 and TM6 [72]. This model of secretin binding is proposed as a
general mechanism for all secretin-like GPCRs. N-terminus of the peptide ligands was shown
to be important for receptor activation (i.e. for CRF, calcitonin, glucagon and VIP) [73–76].
Deletion of this region revealed antagonism for the receptor. And C-terminus of the peptide
was shown to be involved in ligand binding to the receptor (i.e. VIP, PTH and CRF) [77–79].
This binding includes hydrophobic residues of the helical structures on receptor N-terminus,
as well as hydrogen bonds or salt bridges formed between the ligand and polar receptor
residues. In this model, the ligand adopts an α-helical structure upon binding to the receptor.
This is supported by the soluble structures of glucagon, PTH or PACAP in aqueous solution
and their helical structures in organic solvents. Only calcitonin did not change in either media,
due to stabilization by disulfide bridges. The salt bridges between the ligand and the receptor
are thought to be responsible for the helix formation. After forming a binding helix, this
structure is covered by two β-sheets of the receptor N-terminus. Exceptionally, in case of
PACAP binding, the peptide wraps around the helical structures of receptor N-terminus [80].
All the details proposed for ligand binding to secretin-like GPCRs add up to a common model
of “two-domain” binding. The C-terminus of the peptide is responsible for receptor binding,
mostly to the N-terminus of the receptor, producing a conformational change here. And N-
terminus of the peptide enters to the TM region and produces a second conformational change
that will lead to signal transduction.
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6. Methods to study neuropeptide-GPCR interactions
Studying the ligand interaction properties of GPCRs is an essential concept in pharmacology.
Neuropeptide GPCRs contribute to the majority of drug targets in central nervous system
disorders. Also, insect neuropeptide GPCRs are valuable targets for pesticide designs. Finding
the binding sites, discovering agonists, antagonist and even allosteric modulators, understand-
ing the binding affinities and thermodynamic properties and measuring retention times pro-
duce a need for case-specific types of GPCR-ligand interaction studies. These may require
direct, indirect or in silico methods, or a combination of these.
Direct methods for studying GPCR-ligand interactions involve nuclear magnetic resonance
(NMR) spectroscopy, X-ray diffraction and surface plasmon resonance (SPR) techniques. The
information coming from these studies are deposited in Protein Data Bank (PDB) and increas-
ing every day. However, the increase in deposition of GPCR structures is not as fast as that of
soluble protein structures. For instance, most of the data coming from NMR studies include
only partial GPCR structures bound with their ligands. Obtaining pure crystals of GPCRs is a
challenge in X-ray analysis. And studying with hydrophobic ligands is difficult in SPR
method. Therefore, we will not go in detail of these direct methods in this chapter, due to their
challenges in working with membrane-bound proteins.
Indirect methods for studying GPCR-ligand interactions include fluorescent-based methods,
radioligand binding, photoaffinity labeling, luminescence-based methods, force spectroscopy
and activity-based assays.
In silico approaches do not yield direct or indirect evidence for GPCR-ligand interactions, but
they reduce the problem space, facilitate the following assays and qualitative comparisons
between molecules and can mimic the assay conditions, so that they are highly valuable tools
for drug design studies.
In this chapter, we will only focus on the indirect methods that are widely used for GPCR-
ligand interaction.
6.1. Radioligand-binding assays
In principle of radioligand-binding assays, the ligand is previously radiolabeled and added
onto the receptor, and its binding is measured quantitatively. The first study of radioligands on
GPCRs is that of Lefkowitz and his collaborators where they used I125-labeled adrenocortico-
tropic hormone (ACTH) against ACTH receptor [81]. Since then, modifications on the method
made use of membrane patches and also whole cells [82]. With the help of radioligand
saturation binding, indirect binding or kinetic-binding assays can be performed and result in
calculation of EC50, Kd values together with the retention time of the ligand on the receptor.
Also, they show if the ligand binding is reversible or not. The major challenges of this method
are the cost and half-lives of radioligands and the health issues in regard to exposure to them.
Agonists cannot be distinguished from antagonists with these assays. Additionally, optimiza-
tions should be performed to minimize nonspecific binding (i.e. to the cell, to the plastic ware).
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6.2. Photoaffinity labeling
In the study of GPCR-ligand interactions, photoaffinity labeling (PAL) is one of the oldest
methods. Here, the ligand is bound with a photoreactive group (PRG). Upon binding with the
receptor, PRG is activated by UV light and forms an irreversible covalent bond with the closest
residues on the receptor. This approach can be combined with immunoprecipitation and mass
spectrometry to sequence the amino acids that are in proximity to the ligand-binding pocket.
An example can be given as the study of Ceraudo et al. for the interaction between VIP and
VPAC1 receptor. They first labeled the C-terminus of VIP with a photoreactive p-benzoyl-p-
phenylalanine (Bpa) group. Then they followed by cleavage and Edman sequencing. Finally,
they found that the C-terminus of VIP was interacting with the N-terminus of VPAC1 [83].
In another study, Grunbect et al. have performed site-directed mutagenesis on some proposed
residues of CXCR4. These mutant residues were producing amber stop codons, which can be
engineered to incorporate photocrosslinkers (i.e. BzF and azF). They have transfected HEK
cells with these mutant constructs and treated the cells with the ligand. After UV activation,
lysis and immunopurification of the receptor-ligand complexes, they saw that 189F residue of
the receptor was in close proximity to the ligand during binding [84].
6.3. Fluorescence-based methods
The use of fluorescently labeled ligands has many advantages when compared to radioactively
labeled ligands. For instance, detection efficiency is higher in fluorescent ligands, and health
safety issues are easier to handle for the methods utilizing fluorescent ligands. Additionally,
fluorescence-based methods can generate quantitative data as given by radioligand assays (i.e.
EC50, etc.). For instance, microscopy and flow cytometry can be used in real-time experiments;
they can measure the amount of fluorescence that is interacting with or within the cells [85].
Dissociation rate constants (Kd) of fluorescently labeled ligands can be calculated in various
approaches. First, physical separation of bound ligand from free ligand in different fractions
can be measured by means of concentrations. Second, the emission intensity of the ligand
changes upon binding with the receptor and this change can be measured. Third, diffusion
rates of bound and free ligands differ. In an approach called fluorescence correlation spectros-
copy (FCS), diffusion rate of labeled ligand can be measured on a highly sensitive confocal
microscope. Another approach depends on anisotropy, which means that polarization of the
molecule changes between bound and free ligands. As a fifth approach, flow cytometry can be
used to detect presence of labeled ligands on receptor carrying cells or beads. At last, the most
frequently used sensitive approach is called as fluorescence resonance energy transfer (FRET).
There are other methods such as fluorescence recovery after photobleaching (FRAP) that is
similar to FCS in principle. However, this method is used only for GPCR oligomerization or G-
protein coupling until now [86, 87], but no study was performed on GPCR-ligand interactions
yet. Another complex approach combines two-photon excitation microscopy with FCS and
quantum dot technology (TPE-XCS), which seems very promising for the following days [88].
In this chapter, we will give some more detail on FRET experiments performed on GCPR-
ligand studies that are widely preferred by the researchers.
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FRET is based on the energy transfer between two different fluorophores when they come
close to a defined distance (typically between 10 and 100 Å). In principle, emission of first
fluorophore (donor) should excite the second fluorophore (acceptor). In case of GPCR-ligand
interactions, different approaches can be used. First, the ligand and an extracellular domain of
the receptor can be expressed in fusion with different fluorescent proteins. When the ligand is
in proximity to the receptor, two fluorophores also come close to yield an energy transfer. The
difference between the FRET signals of interacting and noninteracting GPCR-ligand couples
gives an information about the presence of interaction. FRET can also be time-resolved so that
information on kinetics of ligand binding can be achieved. This method was used for various
types of receptors such as M1 muscarinic acetylcholine receptor, PTH receptors, neurokinin
NK2 receptor, cholecystokinin receptor and secretin receptor [89–93]. In another approach,
mapping of the ligand-binding region is possible. Here, cysteine residues can be added to
different locations of the proposed binding pocket of GPCR via site-directed mutagenesis.
These cysteine residues can bind with small fluorophores which would not interfere ligand
binding. Additionally, the environment of the ligand-binding pocket can be assessed, via
accessibility of aqueous solution and changes in quenching and polarity upon ligand binding.
In a technique by Hoffman et al., tetracysteine residues were added to ICL3 and C-terminus of
the GPCR. These residues can bind with FlAsH reagent, which is a small fluorophore. When
used in combination with cyan fluorescent protein (CFP), conformational changes upon bind-
ing of the ligand were made possible to detect [93].
6.4. Bioluminescence resonance energy transfer (BRET)
In principle, BRET is similar to FRET by using a bioluminescent donor on one molecule and a
fluorescent acceptor on the target molecule. Generally, a luciferase (i.e. Rluc8) is used as the
donor. It can be performed real time, giving quantitative information about ligand binding. It
is advantageous over FRET, because it does not require an initial illumination of the donor
molecule. As an example, Stoddart et al. performed BRETon beta adrenergic receptor 2 (β2AR)
with an antagonist in live cells. They generated the N-terminus of the receptor with lumines-
cent donor and used a fluorescently labeled ligand [94].
6.5. Atomic force microscopy (AFM)
AFM is based on the principle of single-molecule force spectroscopy, in which binding force of
two singlemolecules is measured as a difference in laser deflection. Onemolecule is bound on the
tip of a cantilever and the other molecule stays on a rigid surface (or on cell surface). If interaction
occurs, the laser deflection from the cantilever tip differs from the state of no-interaction events.
Here, the receptors can be in lipid bilayers, as performed by Pfreundschuh et al. [95] and Alsteens
et al. [96], and binding the ligand to the cantilever tip. Also, the method can utilize the receptors
on live cells directly as performed by our group for AlstR-C receptor [67].
In AFM, direct measurements can be obtained from single molecules, and the controls can be
designed to exclude nonspecific-binding events. There is no need for fluorescent, luminescent or
radiolabeling of the molecules, which may interfere with the binding sites. In most of the cases,
peptide ligands are much smaller than fluorescent proteins. However, in AFM, the peptides can
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be utilized in their native forms, or they can be functionalized from defined terminal sites. The
method in our study also provides the native environment of the receptor as in FRET experi-
ments. And this makes it more advantageous than the methods analyzing purified receptors.
AFM setup is suitable for working on adherent cancer cells for long hours, so that the performer
can take hundreds of data points from the same cell. And ectopic expression produces enough
saturation of the receptor on the surface to detect at each approaching step. Therefore, AFM
seems a promising and easy way to study GPCR-ligand interactions on live cells.
6.6. Activity-based assays
Activity-based assays depend on the previously known downstream effects of the GPCR in cells.
The advantage of these assays is that they allow discrimination of agonists from antagonists and
also partial agonists. Quantification of EC50 values is possible, so that they can also be used in
high-throughput pharmacological studies. Examples can be given as GTPγS (guanosine 5'-O-
[gamma-thio]triphosphate) binding assays, cAMP (cyclic adenosine monophosphate) assays, IP3
(inositol triphosphate) and Ca+2 assays, TGF-α (transforming growth factor alpha) shedding
assay, β-arrestin recruitment and internalization assay, dimerization assays and voltage-clamp
experiments. These assays can be coupled with fluorescent techniques or site-directed mutagen-
esis of the receptor when required.
7. Conclusion
There are at least 80 genes encoding for neuropeptide precursors in human. These precursors
give rise to at least 150 mature neuropeptides. And until now, at least 109 of these peptides
were shown to signal via GPCRs. All these peptides and their cognate GPCRs are still being
studied against the neurological disorders, which range from the simplest stress and pain relief
cases to the complex schizophrenia and Alzheimer’s disease. Therefore, understanding the
kinetics, interactions and transduction pathways of GPCR-neuropeptide signaling systems
will remain crucial for the human wealth.
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